The VERLINTO brand, founded in 2010 (United Kingdom), from 248 sister brands and 17477 competing brands. VERLINTO is a brand of GLAXOSMITHKLINE, listed on the stock exchange of London. The International Securities Identification Number (ISIN) of GLAXOSMITHKLINE is GB0009252882. VERLINTO is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
GLAXOSMITHKLINE
(VERLINTO)
over 5 years*
GBX 1,404.79